Advertisement

COPD pp 3-7 | Cite as

Definition and Epidemiology of COPD

  • Young Sam KimEmail author
Chapter
  • 1.4k Downloads

Abstract

Chronic Obstructive Pulmonary Disease (COPD) is a common disease and prevalence is increasing worldwide. It is characterized by persistent airway obstruction that is partially reversible but it is considered preventable and treatable disease now. Airflow limitation is associated with chronic and abnormal inflammatory response in the airways and the lung to noxious stimuli [1]. Airway obstruction is defined by a reduction of expiratory airflow. Generally, forced expiratory volume in 1 s/forced volume capacity (FEV1/FVC) ratio of less than 70% after bronchodilator has been used to identify COPD patient. The use of lower limit of normal (LLN) values has been proposed to define airflow limitation by spirometry, but current Global initiative for chronic Obstructive Lung Disease (GOLD) and American Thoracic Society/European Respiratory Society guidelines continue to recommend the fixed ratio criteria instead of an LLN for the diagnosis of COPD [1]. Patients with COPD have shown a great deal of heterogeneity and can be classified according to their clinical and radiologic parameters, biomarkers, lung function impairment and prognosis [2]. Traditionally, COPD has been classified as chronic bronchitis (CB) and emphysema. CB is defined as the presence of a chronic productive cough for 3 months in each of two consecutive years. Emphysema is defined as the destruction of alveolar walls and permanent enlargement of the airspaces distal to the terminal bronchioles. Current GOLD guidelines do not include the use of these terms in the definition of COPD. Asthma and COPD represent different disease entity with different pathogeneses and risk factors. Sometimes clinical manifestations of both diseases may overlap in a patient with airway obstruction and cannot be classified as COPD or asthma only. Large population studies show that some of the patients with airway obstruction are classified with more than one diagnosis. Therefore, overlapping diagnoses of asthma and COPD has been proposed and it is called COPD and Asthma Overlap Syndrome (ACOS) [1].

References

  1. 1.
    Diaz-Guzman E, Mannino DM. Epidemiology and prevalence of chronic obstructive pulmonary disease. Clin Chest Med. 2014;35(1):7–16.CrossRefGoogle Scholar
  2. 2.
    Rosenberg SR, Kalhan R, Mannino DM. Epidemiology of chronic obstructive pulmonary disease: prevalence, morbidity, mortality, and risk factors. Semin Respir Crit Care Med. 2015;36(4):457–69.CrossRefGoogle Scholar
  3. 3.
    Lopez AD, et al. Chronic obstructive pulmonary disease: current burden and future projections. Eur Respir J. 2006;27(2):397–412.CrossRefGoogle Scholar
  4. 4.
    Halbert RJ, et al. Global burden of COPD: systematic review and meta-analysis. Eur Respir J. 2006;28(3):523–32.CrossRefGoogle Scholar
  5. 5.
    Ford ES, et al. Trends in the prevalence of obstructive and restrictive lung function among adults in the United States: findings from the National Health and nutrition examination surveys from 1988-1994 to 2007-2010. Chest. 2013;143(5):1395–406.CrossRefGoogle Scholar
  6. 6.
    Menezes AM, et al. Chronic obstructive pulmonary disease in five Latin American cities (the PLATINO study): a prevalence study. Lancet. 2005;366(9500):1875–81.CrossRefGoogle Scholar
  7. 7.
    Buist AS, et al. International variation in the prevalence of COPD (the BOLD study): a population-based prevalence study. Lancet. 2007;370(9589):741–50.CrossRefGoogle Scholar
  8. 8.
    Fukuchi Y, et al. COPD in Japan: the Nippon COPD epidemiology study. Respirology. 2004;9(4):458–65.CrossRefGoogle Scholar
  9. 9.
    Kim DS, et al. Prevalence of chronic obstructive pulmonary disease in Korea: a population-based spirometry survey. Am J Respir Crit Care Med. 2005;172(7):842–7.CrossRefGoogle Scholar
  10. 10.
    Yoo KH, et al. Prevalence of chronic obstructive pulmonary disease in Korea: the fourth Korean National Health and nutrition examination survey, 2008. Respirology. 2011;16(4):659–65.CrossRefGoogle Scholar
  11. 11.
    Zhong N, et al. Prevalence of chronic obstructive pulmonary disease in China: a large, population-based survey. Am J Respir Crit Care Med. 2007;176(8):753–60.CrossRefGoogle Scholar
  12. 12.
    Adeloye D, et al. An estimate of the prevalence of COPD in Africa: a systematic analysis. COPD. 2015;12(1):71–81.CrossRefGoogle Scholar
  13. 13.
    Chapman KR, et al. Epidemiology and costs of chronic obstructive pulmonary disease. Eur Respir J. 2006;27(1):188–207.CrossRefGoogle Scholar
  14. 14.
    Afonso AS, et al. COPD in the general population: prevalence, incidence and survival. Respir Med. 2011;105(12):1872–84.CrossRefGoogle Scholar
  15. 15.
    van Durme YM, et al. Prevalence, incidence, and lifetime risk for the development of COPD in the elderly: the Rotterdam study. Chest. 2009;135(2):368–77.CrossRefGoogle Scholar
  16. 16.
    Krzyzanowski M, Jedrychowski W, Wysocki M. Factors associated with the change in ventilatory function and the development of chronic obstructive pulmonary disease in a 13-year follow-up of the Cracow study. Risk of chronic obstructive pulmonary disease. Am Rev Respir Dis. 1986;134(5):1011–9.CrossRefGoogle Scholar
  17. 17.
    Huhti E, Ikkala J, Hakulinen T. Chronic respiratory disease, smoking and prognosis for life. An epidemiological study. Scand J Respir Dis. 1977;58(3):170–80.PubMedGoogle Scholar
  18. 18.
    Lindberg A, et al. Seven-year cumulative incidence of COPD in an age-stratified general population sample. Chest. 2006;129(4):879–85.CrossRefGoogle Scholar
  19. 19.
    Raherison C, Girodet PO. Epidemiology of COPD. Eur Respir Rev. 2009;18(114):213–21.CrossRefGoogle Scholar
  20. 20.
    Fang X, Wang X, Bai C. COPD in China: the burden and importance of proper management. Chest. 2011;139(4):920–9.CrossRefGoogle Scholar
  21. 21.
    Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med. 2006;3(11):e442.CrossRefGoogle Scholar
  22. 22.
    Mannino DM, Buist AS. Global burden of COPD: risk factors, prevalence, and future trends. Lancet. 2007;370(9589):765–73.CrossRefGoogle Scholar
  23. 23.
    Bustacchini S, et al. The economic burden of chronic obstructive pulmonary disease in the elderly: results from a systematic review of the literature. Curr Opin Pulm Med. 2011;17(Suppl 1):S35–41.CrossRefGoogle Scholar
  24. 24.
    Vos T, et al. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the global burden of disease study 2013. Lancet. 2015;386(9995):743–800.CrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2017

Authors and Affiliations

  1. 1.Division of Pulmonology, Department of Internal MedicineSeverance Hospital, Yonsei University College of MedicineSeoulSouth Korea

Personalised recommendations